RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/SHA-384/106D6D0EE883A668708B7113A07BDE44B060483DBD007AB75D6D98177F42DB276B2871FBC0D26817971A213E414A075Bhttp://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/106D6D0EE883A668708B7113A07BDE44B060483DBD007AB75D6D98177F42DB276B2871FBC0D26817971A213E414A075Bhttp://www.w3.org/2000/01/rdf-schema#comment"We identified 32 compound heterozygous mutations and 9 homozygous mutations in IL10 receptor subunit alpha and 1 homozygous mutation in IL10 receptor subunit beta. Among these mutations 10 novel mutations were identified and 6 pathogenic mutations had been previously described. In patients with IL10 receptor subunit alpha mutations c.301C>T (p.R101RW) and c.537 G>A (p.T179T) were the most common mutations."xsd:string
http://purl.uniprot.org/uniprot/#_5C59FBB448AE4EC77D74B164938BA9D298F43F1C72C221E56681E154C47171D819BB764FD667005984D8D951C6F5D5A0http://www.w3.org/1999/02/22-rdf-syntax-ns#subjecthttp://purl.uniprot.org/SHA-384/106D6D0EE883A668708B7113A07BDE44B060483DBD007AB75D6D98177F42DB276B2871FBC0D26817971A213E414A075B
http://purl.uniprot.org/uniprot/Q13651http://purl.uniprot.org/core/mappedAnnotationhttp://purl.uniprot.org/SHA-384/106D6D0EE883A668708B7113A07BDE44B060483DBD007AB75D6D98177F42DB276B2871FBC0D26817971A213E414A075B
http://purl.uniprot.org/uniprot/#_Q13651-mappedCitation-28267044http://purl.uniprot.org/core/mappedAnnotationhttp://purl.uniprot.org/SHA-384/106D6D0EE883A668708B7113A07BDE44B060483DBD007AB75D6D98177F42DB276B2871FBC0D26817971A213E414A075B